These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. Galici R; Echemendia NG; Rodriguez AL; Conn PJ J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306 [TBL] [Abstract][Full Text] [Related]
12. 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators. Jimenez HN; Liu KG; Hong SP; Reitman MS; Uberti MA; Bacolod MD; Cajina M; Nattini M; Sabio M; Doller D Bioorg Med Chem Lett; 2012 May; 22(9):3235-9. PubMed ID: 22465637 [TBL] [Abstract][Full Text] [Related]
13. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators. Bennett KA; Christopher JA; Tehan BG Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence. Dhanya RP; Sheffler DJ; Dahl R; Davis M; Lee PS; Yang L; Nickols HH; Cho HP; Smith LH; D'Souza MS; Conn PJ; Der-Avakian A; Markou A; Cosford ND J Med Chem; 2014 May; 57(10):4154-72. PubMed ID: 24735492 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders. Gregory KJ; Noetzel MJ; Niswender CM Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. Engers JL; Rodriguez AL; Konkol LC; Morrison RD; Thompson AD; Byers FW; Blobaum AL; Chang S; Venable DF; Loch MT; Niswender CM; Daniels JS; Jones CK; Conn PJ; Lindsley CW; Emmitte KA J Med Chem; 2015 Sep; 58(18):7485-500. PubMed ID: 26335039 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models. Shu Y; Diamond TL; Hershey JC; Huang S; Magliaro BC; O'Brien JA; Schlegel KS; Puri V; Uebele VN; Uslaner JM; Wang C; Converso A Bioorg Med Chem Lett; 2020 May; 30(9):127066. PubMed ID: 32173198 [TBL] [Abstract][Full Text] [Related]
19. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache. Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs. Wenthur CJ; Morrison RD; Daniels JS; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2014 Jun; 24(12):2693-8. PubMed ID: 24794112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]